Initial Treatment With Tebentafusp Show Significant OS Improvement in Metastatic Uveal Melanoma
…potential to be practice-changing in uveal melanoma.” Uveal melanoma is a rare disease with a low mutational burden and a…
Initial Treatment With Tebentafusp Show Significant OS Improvement in Metastatic Uveal Melanoma
…potential to be practice-changing in uveal melanoma.” Uveal melanoma is a rare disease with a low mutational burden and a…
,
,
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Combination with Pembrolizumab in Advanced Melanoma at ASCO 2021 Annual Meeting
…a potential additive effect for early-line treatment of patients with melanoma. I look forward to investigating this treatment approach in…
,
Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced Melanoma
…advanced melanoma earlier this year.“We are thrilled with FDA’s decision to grant both Fast Track and Orphan Drug Designation to…
,
,
FDA Approves KEYTRUDA for Stage IIB and IIC Melanoma Patients
…their melanoma returning.” Patients will appreciate this new treatment option after a Stage IIB or IIC diagnosis. “Melanoma patients will…
,
,
Coolibar’s Generous Donation to the AIM at Melanoma Foundation
…at Melanoma’s Mission AIM at Melanoma Foundation is committed to supporting patients with melanoma, educating the public about sun safety,…
,
AIM at Melanoma’s 4th Annual Evening in Memory of Valerie Guild
On Saturday, May 31st, AIM supporters, including many influential figures in the melanoma community, gathered for AIM at Melanoma’s 4th…
,
Julie Frampton: Part of the Solution
…M.D. Anderson Cancer Center for the surgery, a second opinion on the pathology report, and a diagnosis. Her melanoma is…
,
,
President’s Letter |September 2020
From the Desk of Samantha Guild The f all is upon us, and here at AIM at Melanoma, we’re busy…
,
Have You Checked Out Our New Website?
…new content has been added. All of those affected by melanoma—whether you are newly diagnosed, currently undergoing treatment for melanoma,…
International Survivor Spotlight: José Correia, Portugal
…after 24 years,” he said. Still, he did think about the need for more information and resources for melanoma prevention…
,
,
Recent Posts
Mar. 26, 2026
Wade Watson, Stage III Melanoma Survivor: A Marathon, Not a Sprint
Mar. 03, 2026
Cancer is More Than a Diagnosis: Mind, Meaning, and Healing
Feb. 19, 2026
Merlin CP-GEP Becomes the First and Only Gene Expression Profile Test Recommended by NCCN®
Feb. 05, 2026
Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma
Jan. 23, 2026